EUVIMEDEUVIMED entdecken
Crossref

Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography‐tandem mass spectrometry

Junfeng Zhu iD, Like Zhong, Yu Song, Haiying Ding, Wenxiu Xin, Gaoqi Xu, Luo Fang

Journal of Separation Science · 2024

DOI: 10.1002/jssc.202300923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Separation Science, 2024. Verfasst von Junfeng Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Chemical and Drug Induced Liver Injury, Drugs, Chinese Herbal, Phenylurea Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Key R & D Program of Zhejiang Province, Zhejiang Provincial Project of Medical and Health Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regorafenib is a small‐molecule tyrosine kinase inhibitor with severe hepatotoxicity. It undergoes metabolism mainly by CYP3A4 to generate active metabolites regorafenib‐ N ‐oxide (M2) and N ‐desmethyl‐regorafenib‐ N ‐oxide (M5). Wuzhi capsule (WZC) is an herbal preparation derived from Schisandra sphenanthera and is potentially used to prevent regorafenib‐induced hepatotoxicity. This study aims to explore the effect of WZC on the pharmacokinetics of regorafenib in rats. An efficient and sensitive liquid chromatography‐tandem mass spectrometry method was developed to quantitatively determine regorafenib and its main metabolites in rat plasma. The proposed method was applied to the pharmacokinetic study of regorafenib in rats, with or without WZC. Coadministration of regorafenib with WZC resulted in a prolonged mean residence time (MRT) of the parent drug but had no statistically significant difference in other pharmacokinetic parameters. While for the main metabolites of regorafenib, WZC decreased the area under the curve and maximum concentration (C max ), delayed the time to reach C max , and prolonged the MRT of M2 and M5. These results indicate that WZC delayed and inhibited the metabolism of regorafenib to M2 and M5 by suppressing CYP3A4. Our study provides implications for the rational use of the WZC‐regorafenib combination in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3AChemical and Drug Induced Liver InjuryDrugs, Chinese HerbalPhenylurea CompoundsPyridinesAnimalsRatsTandem Mass SpectrometryChromatography, LiquidOxides

Stichwörter der Autor:innen

Schisandra sphenantheraherb-drug interactionliquid chromatography-tandem mass spectrometrypharmacokinetic studyregorafenib

Substanzen

regorafenibwuzhiCytochrome P-450 CYP3AOxidesDrugs, Chinese HerbalPhenylurea CompoundsPyridines

Autor:innen und Institutionen

  • Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.

ORCID-Profile: Junfeng Zhu

Förderung

  • Key R & D Program of Zhejiang Province
  • Zhejiang Provincial Project of Medical and Health Technology

Zitieren

APA

Zhu, J., Zhong, L., Song, Y., Ding, H., Xin, W., Xu, G., & Fang, L. (2024). Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography‐tandem mass spectrometry. Journal of Separation Science. https://doi.org/10.1002/jssc.202300923

Vancouver

Zhu J, Zhong L, Song Y, Ding H, Xin W, Xu G, et al. Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography‐tandem mass spectrometry. Journal of Separation Science. 2024. doi:10.1002/jssc.202300923

BibTeX
@article{Zhu2024,
  author = {Zhu, Junfeng and Zhong, Like and Song, Yu and Ding, Haiying and Xin, Wenxiu and Xu, Gaoqi and Fang, Luo},
  title = {Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography‐tandem mass spectrometry},
  journal = {Journal of Separation Science},
  year = {2024},
  doi = {10.1002/jssc.202300923}
}
Kostenlos starten →